NEW YORK (GenomeWeb) – While still not so widespread as single-cell genomics or transcriptomics, single-cell protein analyses have gained traction in recent years with companies like Nanostring, Fluidigm, IsoPlexis, and Bio-Techne developing single-cell proteomic offerings.

By and large, though, these systems have relied on immunoassays. And while technologies like Fluidigm's mass cytometry platforms offer relatively high levels of multiplexing for an antibody-based system, they remain limited in terms of the breadth of proteomic profiles they can generate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.